Endovascular therapy for isolated M2 occlusion in patients with ischemic stroke: A propensity score-matched analysis
Authors:
- Noriyuki SaharaNSNoriyuki Sahara
- Go HashimotoGHGo Hashimoto
- Kuniyuki NakamuraKNKuniyuki Nakamura
- Fumi IrieFIFumi Irie
- Takuya KiyoharaTKTakuya Kiyohara
- Yoshinobu WakisakaYWYoshinobu Wakisaka
- Ryu MatsuoRMRyu Matsuo
- Masahiro KamouchiMKMasahiro Kamouchi
- Tetsuro AgoTATetsuro Ago
Open Access
- 28 May 2026
- journal article
- Published by S. Karger AG in Cerebrovascular Diseases Extra
- Vol. 16 (1) , 1-19
Abstract
Introduction Endovascular therapy (EVT) is an established treatment for large vessel occlusion in patients with acute ischemic stroke; however, its efficacy for medium vessel occlusions, particularly isolated M2 segment occlusions, remains uncertain. As M2 occlusions are relatively proximal among medium vessel occlusions and can cause disabling neurological deficits, clarifying the role of EVT is clinically important. In this study, we aimed to evaluate the efficacy and safety of EVT compared with best medical management (BMM) in patients with acute isolated M2 occlusion using data from a multicentre registry. Methods We analysed the data of patients from a multicentre stroke registry who had an isolated M2 occlusion, had arrived within 24 hours of onset, and were functionally independent before stroke. Data on baseline demographics, vascular risk factors, stroke characteristics, and treatment were collected. Propensity score matching generated 100 well-balanced pairs of EVT- and BMM-treated patients. The primary outcomes were favourable functional outcomes (modified Rankin Scale [mRS] score of 0–2 or 0–1) and mortality at discharge and 3 months. The secondary outcomes included neurological improvement or deterioration and haemorrhagic complications during hospitalisation. Results Among 594 eligible patients (EVT, n = 118; BMM, n = 476), data from 100 matched pairs were analysed. At 3 months, good functional outcomes (mRS score of 0–2: 49% EVT vs. 46% BMM) and mortality (7% vs. 9%) were comparable, with consistent findings at discharge. EVT was associated with higher rates of any intracranial haemorrhage (46% vs. 21%), although the symptomatic intracranial haemorrhage rates were identical (5%). In exploratory subgroup analyses, a significant interaction with onset-to-door time was observed for mRS score of 0–2 (p = 0.03), whereas no significant interaction was detected for mRS score of 0–1 or mortality. Conclusion In this multicentre registry of patients with isolated M2 occlusion, EVT was not associated with superior functional outcomes or reduced mortality, compared with BMM. Although exploratory analyses suggested possible heterogeneity of treatment effect according to clinical factors, such as time from onset, these findings should be interpreted cautiously. Overall, the results highlight the heterogeneity of M2 occlusions and underscore the need for adequately powered randomised trials to inform individualised treatment decisions.Keywords
This publication has 22 references indexed in Scilit:
- Endovascular treatment achieves better outcomes than best medical management in patients with M2 occlusion and high stroke severity: a meta-analysisJournal of Neurology, 2023
- Endovascular treatment versus intravenous thrombolysis alone in isolated M2 occlusion: a meta-analysisNeurological Sciences, 2021
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in StrokeNew England Journal of Medicine, 2015
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic StrokeNew England Journal of Medicine, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2015
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007